These results, together with a former report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 help the principle of focusing on ACKR3 as a unique strategy to modulate the opioid program, which could open up new therapeutic avenues for opioid-related Diseases. The internet site is https://billm517vto2.wikibestproducts.com/user